发明名称 Method of inhibiting binding or activity of MIF by administering a MIF antagonist
摘要 Methods and compositions for using the MHC class II invariant chain polypeptide, Ii (also known as CD74), as a receptor for macrophage migration inhibitory factor (MIF), are disclosed. These include methods and compositions for using this receptor, as well as agonists and antagonists of MIF which bind to this receptor, or which otherwise modulate the interaction of MIF with CD74 or the consequences of such interaction, in treatment of conditions characterized by locally or systemically altered MIF levels, particularly inflammatory conditions and cancer.
申请公布号 US9221903(B2) 申请公布日期 2015.12.29
申请号 US201314090183 申请日期 2013.11.26
申请人 Baxalta Incorporated;Baxalta GmbH 发明人 Bucala Richard J.;Leng Lin;Metz Christine N.
分类号 A61K38/16;A61K38/17;A61K38/19;A61K35/00;C07K16/24;G01N33/50;G01N33/68;C07K16/28;C07K16/40;C12N9/90;C12N15/113;C07K14/47;C07K14/52;A61K39/00 主分类号 A61K38/16
代理机构 Morgan, Lewis & Bockius LLP 代理人 Morgan, Lewis & Bockius LLP
主权项 1. A method of inhibiting the binding of macrophage migration inhibitory factor (MIF) on a cell comprising on the surface an MHC class II invariant chain (Ii) polypeptide, said method comprising: contacting said cell with an antagonist of MIF wherein said antagonist is a recombinant polypeptide comprising a MIF protein-binding fragment of the amino acid sequence of SEQ ID NO:2, and wherein said cell is present in a mammal suffering from a B cell cancer, thereby inhibiting the binding of MIF to said Ii polypeptide.
地址 Bannockburn IL US